Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL
Clinical trial NCT01400685 · COMPLETED
Trial details
- NCT number
- NCT01400685
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2017-12-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.